Skip to the main content

Biochemia Medica, Vol. 33 No. 1, 2023.

Original scientific paper

https://doi.org/10.11613/BM.2023.010701

Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients

Adnan Haşimi ; Department of Medical Biochemistry, Faculty of Medicine, Medipol University, Istanbul, Turkey
Özlem Doğan ; Department of Biochemistry, Ankara University School of Medicine, Ankara, Turkey
Ceyhan Ceran Serdar ; Medical Biology and Genetics, Faculty of Medicine, Ankara Medipol University, Ankara, Turkey
Muhittin A. Serdar ; Department of Medical Biochemistry, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey

Full text: english pdf 548 Kb

page 21-31

downloads: 195

cite

Abstract

IntroductionThis study determines and compares the concentrations of arginine and methylated arginine products ((asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), n-monomethyl-1-arginine (L-NMMA) and homoarginine (HA)) for assessment of their association with disease severity in serum samples of COVID-19 patients.
Materials and methodsSerum arginine and methylated arginine products of 57 mild-moderate and 29 severe (N = 86) COVID-19 patients and 21 controls were determined by tandem mass spectrometry. Moreover, the concentrations of some of the routine clinical laboratory parameters -neutrophil lymphocyte ratio (NLR), C-reactive protein, ferritin, D-dimer, and fibrinogen measured during COVID-19 follow-up were also taken into consideration and compared with the concentrations of arginine and methylated arginine products.
ResultsSerum ADMA, SDMA and L-NMMA were found to be significantly higher in severe COVID-19 patients, than in both mild-moderate patients and the control group (P < 0.001 for each). In addition, multiple logistic regression analysis indicated L-NMMA (cut-off =120 nmol/L OR = 34, 95% confidence interval (CI) = 3.5-302.0, P= 0.002), CRP (cut-off = 32 mg/L, OR = 37, 95% CI = 4.8-287.0, P < 0.001), and NLR (cut-off = 7, OR = 22, 95% CI = 1.4-335.0, P = 0.020) as independent risk factors for identification of severe patients.
ConclusionsThe concentration of methylated arginine metabolites are significantly altered in COVID-19 disease. The results of this study indicate a significant correlation between the severity of COVID-19 disease and concentrations of CRP, NLR and L-NMMA.

Keywords

SARS-CoV-2; asymmetric dimethylarginine (ADMA); N-monomethyl-1 -arginine (L-NMMA); prognosis

Hrčak ID:

287722

URI

https://hrcak.srce.hr/287722

Publication date:

15.2.2023.

Visits: 701 *